Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (351-360 of 359) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 359 results.
Nature Communications|August 4, 2021
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous systemAlexander Bolaender, Danuta Zatorska, Huazhong He, et al.
Cancer Discovery|November 23, 2018
<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i>-Amplified Esophagogastric CancerFrancisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, et al.
Cancer Cell|June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunityAndrew Chow, Sara Schad, Michael D Green, et al.
Nature|October 6, 2016
The epichaperome is an integrated chaperome network that facilitates tumour survivalAnna Rodina, Tai Wang, Pengrong Yan, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
The Lancet. Oncology|October 3, 2024
Radiotherapy and theranostics: a Lancet Oncology CommissionMay Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Nature Medicine|June 28, 2024
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancerLinda Bojmar, Constantinos P Zambirinis, Jonathan M Hernandez, et al.
Nature Reviews. Clinical Oncology|October 12, 2016
Imaging biomarker roadmap for cancer studiesJames P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Pageof 36

Showing results (351-360 of 359) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 359 results.
Nature Communications|August 4, 2021
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous systemAlexander Bolaender, Danuta Zatorska, Huazhong He, et al.
Cancer Discovery|November 23, 2018
<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i>-Amplified Esophagogastric CancerFrancisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, et al.
Cancer Cell|June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunityAndrew Chow, Sara Schad, Michael D Green, et al.
Nature|October 6, 2016
The epichaperome is an integrated chaperome network that facilitates tumour survivalAnna Rodina, Tai Wang, Pengrong Yan, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
The Lancet. Oncology|October 3, 2024
Radiotherapy and theranostics: a Lancet Oncology CommissionMay Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Nature Medicine|June 28, 2024
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancerLinda Bojmar, Constantinos P Zambirinis, Jonathan M Hernandez, et al.
Nature Reviews. Clinical Oncology|October 12, 2016
Imaging biomarker roadmap for cancer studiesJames P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Pageof 36